Uptake of community- versus clinic-based antiretroviral therapy dispensing in the Central Chronic Medication Dispensing and Distribution program in South Africa

Introduction: South Africa's government-led Central Chronic Medication Dispensing and Distribution (CCMDD) program offers people living with HIV the option to collect antiretroviral therapy at their choice of community- or clinic-based pick-up points intended to increase convenience and deconge...

Full description

Bibliographic Details
Main Authors: Bassett, I.V (Author), Bogart, L.M (Author), Bunda, B.A (Author), Dube, N. (Author), Govere, S. (Author), Khumalo, A. (Author), Ngobese, N. (Author), Nzuza, M. (Author), Parker, R.A (Author), Shazi, Z. (Author), Stuckwisch, A. (Author), Tshabalala, S. (Author), Wara, N.J (Author), Yan, J. (Author), Zionts, D. (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2022
Subjects:
age
Online Access:View Fulltext in Publisher
LEADER 04637nam a2200661Ia 4500
001 10-1002-jia2-25877
008 220420s2022 CNT 000 0 und d
020 |a 17582652 (ISSN) 
245 1 0 |a Uptake of community- versus clinic-based antiretroviral therapy dispensing in the Central Chronic Medication Dispensing and Distribution program in South Africa 
260 0 |b John Wiley and Sons Inc  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1002/jia2.25877 
520 3 |a Introduction: South Africa's government-led Central Chronic Medication Dispensing and Distribution (CCMDD) program offers people living with HIV the option to collect antiretroviral therapy at their choice of community- or clinic-based pick-up points intended to increase convenience and decongest clinics. To understand CCMDD pick-up point use among people living with HIV, we evaluated factors associated with uptake of a community- versus clinic-based pick-up point at CCMDD enrolment. Methods: We collected baseline data from October 2018 to March 2020 on adults (≥18 years) who met CCMDD clinical eligibility criteria (non-pregnant, on antiretroviral therapy for ≥1 year and virologically suppressed) as part of an observational cohort in seven public clinics in KwaZulu-Natal. We identified factors associated with community-based pick-up point uptake and fit a multivariable logistic regression model, including age, gender, employment status, self-perceived barriers to care, self-efficacy, HIV-related discrimination, and perceived benefits and challenges of CCMDD. Results and Discussion: Among 1521 participants, 67% were females, with median age 36 years (IQR 30–44). Uptake of a community-based pick-up point was associated with younger age (aOR 1.18 per 10-year decrease, 95% CI 1.05–1.33), being employed ≥40 hours per week (aOR 1.42, 95% CI 1.10–1.83) versus being unemployed, no self-perceived barriers to care (aOR 1.42, 95% CI 1.09–1.86) and scoring between 36 and 39 (aOR 1.44, 95% CI 1.03–2.01) or 40 (aOR 1.91, 95% CI 1.39–2.63) versus 10–35 on the self-efficacy scale, where higher scores indicate greater self-efficacy. Additional factors included more convenient pick-up point location (aOR 2.32, 95% CI 1.77–3.04) or hours (aOR 5.09, 95% CI 3.71–6.98) as perceived benefits of CCMDD, and lack of in-clinic follow-up after a missed collection date as a perceived challenge of CCMDD (aOR 4.37, 95% CI 2.30–8.31). Conclusions: Uptake of community-based pick-up was associated with younger age, full-time employment, and systemic and structural factors of living with HIV (no self-perceived barriers to care and high self-efficacy), as well as perceptions of CCMDD (convenient pick-up point location and hours, lack of in-clinic follow-up). Strategies to facilitate community-based pick-up point uptake should be tailored to patients’ age, employment, self-perceived barriers to care and self-efficacy to maximize the impact of CCMDD in decongesting clinics. © 2022 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society. 
650 0 4 |a adult 
650 0 4 |a Adult 
650 0 4 |a age 
650 0 4 |a Ambulatory Care Facilities 
650 0 4 |a antiretroviral therapy 
650 0 4 |a article 
650 0 4 |a cohort analysis 
650 0 4 |a Cohort Studies 
650 0 4 |a controlled study 
650 0 4 |a eligibility criteria 
650 0 4 |a employment 
650 0 4 |a employment status 
650 0 4 |a female 
650 0 4 |a Female 
650 0 4 |a follow up 
650 0 4 |a full time employment 
650 0 4 |a gender 
650 0 4 |a HIV Infections 
650 0 4 |a human 
650 0 4 |a Human immunodeficiency virus infected patient 
650 0 4 |a Human immunodeficiency virus infected patient 
650 0 4 |a Humans 
650 0 4 |a major clinical study 
650 0 4 |a male 
650 0 4 |a multicenter study 
650 0 4 |a perception 
650 0 4 |a self concept 
650 0 4 |a South Africa 
650 0 4 |a South Africa 
650 0 4 |a unemployment 
700 1 0 |a Bassett, I.V.  |e author 
700 1 0 |a Bogart, L.M.  |e author 
700 1 0 |a Bunda, B.A.  |e author 
700 1 0 |a Dube, N.  |e author 
700 1 0 |a Govere, S.  |e author 
700 1 0 |a Khumalo, A.  |e author 
700 1 0 |a Ngobese, N.  |e author 
700 1 0 |a Nzuza, M.  |e author 
700 1 0 |a Parker, R.A.  |e author 
700 1 0 |a Shazi, Z.  |e author 
700 1 0 |a Stuckwisch, A.  |e author 
700 1 0 |a Tshabalala, S.  |e author 
700 1 0 |a Wara, N.J.  |e author 
700 1 0 |a Yan, J.  |e author 
700 1 0 |a Zionts, D.  |e author 
773 |t Journal of the International AIDS Society